Wright Medical Group, Inc. Reports Results for the Fourth Quarter Ended December 31, 2010

Wright Medical Group, Inc. WMGI today reported financial results for its fourth quarter ended December 31, 2010. Net sales totaled $138.3 million during the fourth quarter ended December 31, 2010, representing a 6% increase over net sales of $129.9 million during the fourth quarter of 2009. Excluding the impact of foreign currency, net sales increased 7% during the fourth quarter. Net income for the fourth quarter of 2010 totaled $8.9 million or $0.22 per diluted share, compared to net income of $2.2 million or $0.06 per diluted share in the fourth quarter of 2009. Net income for the fourth quarter of 2010 included the after-tax effects of approximately $3.0 million of non-cash stock-based compensation expense and $1.3 million of expenses associated with our deferred prosecution agreement (DPA). Net income for the fourth quarter of 2009 included the after-tax effects of approximately $5.6 million of charges to write down a significant international receivable, $3.0 million of non-cash stock-based compensation expense, $2.6 million of non-cash charges to write-off cumulative translation adjustment (CTA) balances associated with the substantially complete liquidation of certain foreign subsidiaries, and $2.6 million of restructuring charges. Fourth quarter net income, as adjusted, totaled $11.8 million, or $0.29 per diluted share, in 2010 compared to net income, as adjusted, of $10.8 million, or $0.27 per diluted share for the fourth quarter of 2009. A reconciliation of U.S. GAAP to “as adjusted” results is included in the attached financial tables.